Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma

NCT04197882 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University Cancer Hospital & Institute